Grace Therapeutics, Inc. Liquidation Value Calculator
Grace Therapeutics, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 71 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash total | $1.19M | USD | ||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$18.67M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$18.67M | USD | ||
| Cash Equivalents At Carrying Value total CashEquivalentsAtCarryingValue |
$17.48M | USD | ||
| current_liabilities | ||||
| Employee Related Liabilities Current total EmployeeRelatedLiabilitiesCurrent |
$550,000 | USD | ||
| Other Accrued Liabilities Current total OtherAccruedLiabilitiesCurrent |
$195,000 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$1.28M | USD | ||
| liabilities_total | ||||
| Liabilities total | $3.60M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
15.5M | shares | ||
Unmapped Tags (60)
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $1.28M | USD | ||
| Accounts Payable Trade Current AccountsPayableTradeCurrent | $114,000 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $298.23M | USD | ||
| Assets Assets | $68.49M | USD | ||
| Assets Current AssetsCurrent | $19.21M | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $100.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $15.47M | shares | ||
| Common Stock Value CommonStockValue | $1,000 | USD | ||
| Goodwill Goodwill | $8.14M | USD | ||
| Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill | $41.13M | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $547,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $68.49M | USD | ||
| Nontrade Receivables Current NontradeReceivablesCurrent | $20,000 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Preferred Stock Value PreferredStockValue | $0 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-227.30M | USD | ||
| Stockholders Equity StockholdersEquity | $64.89M | USD | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | $108,000 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $-3.46M | USD | ||
| Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit | $0 | USD | ||
| Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet | $2.31M | USD | ||
| Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade | $-320,000 | USD | ||
| Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense | $66,000 | USD | ||
| Increase Decrease In Receivables IncreaseDecreaseInReceivables | $-106,000 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $3.71M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $0 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-7.17M | USD | ||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $327,000 | USD | ||
| Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments | $0 | USD | ||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | $0 | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $4.04M | USD | ||
| Share Based Compensation ShareBasedCompensation | $616,000 | USD | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax | $-6.04M | USD | ||
| Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax | $-6.62M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-0 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $6.08M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-6.62M | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $0 | USD | ||
| Net Income Loss NetIncomeLoss | $-6.62M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $1.45M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-8.07M | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $519,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.99M | USD | ||
| Depreciation Depreciation | $5,000 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-900,000 | USD | ||
| Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings | $-900,000 | USD | ||
| Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues | $0 | USD | ||
| Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | $241,000 | USD | ||
| Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | $0 | USD | ||
| Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized | $5,000 | USD | ||
| Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue | $0 | USD | ||
| Machinery And Equipment Gross MachineryAndEquipmentGross | $11,000 | USD | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | Segment | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $4.28M | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.